This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

SOHO 2026 Annual Meeting

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Topics

Select Topic

Showing 230 results for "Acute Myeloid Leukemia (AML)".

Thumbnail for Clinical Outcomes of Venetoclax-Decitabine Therapy in Older Patients With Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis

AML - 1295

Clinical Outcomes of Venetoclax-Decitabine Therapy in Older Patients With Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis

Bashar M Al Zoubi

Poster Presenter: Bashar M Al Zoubi

$Thumbnail for Actinomycin D in Combination with Low-dose Cytarabine and Venetoclax in Relapsed or Refractory NPM1-mutated Acute Myeloid Leukemia$

AML - 1299

Actinomycin D in Combination with Low-dose Cytarabine and Venetoclax in Relapsed or Refractory NPM1-mutated Acute Myeloid Leukemia

Tautvil? Smalinskait?

Poster Presenter: Tautvile Smalinskaite

Previous 1...4 5 6 7 8 9 10...26 Next

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

Back

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Topics

Select Topic

Showing 230 results for "Acute Myeloid Leukemia (AML)".

AML - 1295

Clinical Outcomes of Venetoclax-Decitabine Therapy in Older Patients With Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis

Bashar M Al Zoubi

Poster Presenter: Bashar M Al Zoubi

$Thumbnail for Actinomycin D in Combination with Low-dose Cytarabine and Venetoclax in Relapsed or Refractory NPM1-mutated Acute Myeloid Leukemia$

AML - 1299

Actinomycin D in Combination with Low-dose Cytarabine and Venetoclax in Relapsed or Refractory NPM1-mutated Acute Myeloid Leukemia

Tautvil? Smalinskait?

Poster Presenter: Tautvile Smalinskaite

Previous 1...4 5 6 7 8 9 10...26 Next

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Prognostic Significance of tRNA Methyltransferase Expression in Intermediate-Risk Acute Myeloid Leukemia

Christine Wilson

Poster Presenter: Christine Wilson

AML - 1312

Clinical Outcomes of ETO Positive Acute Myeloid Leukemia: A Single-Center Experience From Pakistan

Zara Tul Ain

Poster Presenter: Zara Tul Ain

Thumbnail for Efficacy and Toxicity of FLAG-IDA-Venetoclax Compared With Other Induction Regimens in Newly Diagnosed and Relapsed AML: A Real-World Single-Center Study

AML - 132

Efficacy and Toxicity of FLAG-IDA-Venetoclax Compared With Other Induction Regimens in Newly Diagnosed and Relapsed AML: A Real-World Single-Center Study

Rita Ahmad

Poster Presenter: Rita Ahmad

Thumbnail for Melatonin Enhances Venetoclax Sensitivity Through Modulation of Apoptotic and Resistance Pathways in Acute Myeloid Leukemia

AML - 1321

Melatonin Enhances Venetoclax Sensitivity Through Modulation of Apoptotic and Resistance Pathways in Acute Myeloid Leukemia

Joao Agostinho Machado-Neto

Poster Presenter: Joao Agostinho Machado-Neto

$Thumbnail for Efficacy and Safety of Triplet Targeted Therapy for FLT3-Mutated Relapsed/Refractory AML: A Systematic Review and Proportion Meta-Analysis$

AML - 1336

Efficacy and Safety of Triplet Targeted Therapy for FLT3-Mutated Relapsed/Refractory AML: A Systematic Review and Proportion Meta-Analysis

Mehak Dang

Poster Presenter: Mehak Dang

AML - 1351

MRD-Guided Risk Stratification in Venetoclax-Treated Newly Diagnosed AML: A Pooled Survival Analysis

Nuri Tamanna

Poster Presenter: Nuri Tamanna

AML - 1354

Risk Stratification of Patients Treated for NPM1 Mutated Acute Myeloid Leukemia: A Single Center Retrospective Study.

Mohammed Almakadi

Poster Presenter: Mohammed Almakadi

ePosters in

Topics Sessions

Previous 1 2 Next